Morphine and P2Y12 Inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis
Authors:
- Ryan BerryRBRyan Berry
- Khaled M. HarmouchKHKhaled M. Harmouch
- Alaa RotoARAlaa Roto
- Nomesh KumarNKNomesh Kumar
- Zohaib KhanZKZohaib Khan
- Resha KhanalRKResha Khanal
- Mohammad HamzaMHMohammad Hamza
- Yasemin BaharYBYasemin Bahar
- Yasar SattarYSYasar Sattar
- Wael AljaroudiWAWael Aljaroudi
- Timir K. PaulTPTimir K. Paul
- M. Chadi AlraiesMAM. Chadi Alraies
- 19 December 2024
- journal article
- research article
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 25 (3) , 389-398
Abstract
Background Morphine is used to control pain in ST-elevation myocardial infarction but reduces P2Y12 inhibition. It is not known if this modulation of platelet inhibition appreciably affects clinical outcomes. Methods We screened 979 articles and identified seven studies that met the eligibility criteria for meta-analysis. Outcomes included 11 metrics across angiographic and clinical domains. A random effects model assessed heterogeneity between studies. Results The opiate group showed decreased achievement of postprocedural thrombolysis in myocardial infarction (TIMI) 2 flow relative to placebo [risk ratio (RR) 0.71, 95% confidence interval (CI) 0.52–0.97, p = 0.03, I2 = 0.0%]. All other metrics listed below showed no statistically significant difference between groups: infarct size, microvascular obstruction, microvascular/salvage index, absence of pre- percutaneous coronary intervention (PCI) TIMI 3 flow, postprocedural TIMI 2 flow, postprocedural TIMI 3 flow, all-cause mortality, stroke, repeat MI, unstable angina, and left ventricular ejection fraction. However, there were no statistically significant differences in infarct size [odds ratio (OR) − 0.12, 95% CI − 0.37 to 0.17, p = 0.42], microvascular obstruction [standard mean difference (SMD) = 0.02, 95% CI − 0.12 to 0.16, p = 0.82], microvascular obstruction/salvage index (SMD = − 0.05, 95% CI − 0.24 to 0.13, p = 0.57), absence of pre-PCI TIMI 3 flow (OR 0.98, 95% CI 0.79–1.22, p = 0.87), and postprocedural TIMI 3 flow (OR 1.23, 95% CI 0.84–1.79, p = 0.28) between the two groups. Conclusions In STEMI, opiates correlate with worse angiographic outcomes, specifically postprocedural TIMI 2 flow. However, this observation does not appear to be clinically consequential.Keywords
This publication has 26 references indexed in Scilit:
- Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: A meta-analysis of comparative studiesThe American Journal of Emergency Medicine, 2023
- Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: A meta-analysisThe American Journal of Emergency Medicine, 2021
- Impact of Preadmission Morphine on Reinfarction in Patients With ST‐Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta‐AnalysisClinical Pharmacology & Therapeutics, 2020
- Association of periprocedural intravenous morphine use on clinical outcomes in ST‐elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta‐analysisCatheterization and Cardiovascular Interventions, 2019
- Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-MorphineAmerican Journal of Cardiovascular Drugs, 2018
- Clinical Pharmacokinetics and Pharmacodynamics of ClopidogrelClinical Pharmacokinetics, 2015
- Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions2014
- Letter to the EditorAmerican Heart Journal, 2005
- Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement InitiativeAmerican Heart Journal, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002